Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jörg Kotzka

A Variant of the Glucose Transporter Gene SLC2A2 Modifies the Glycaemic Response to Metformin Therapy in Recently Diagnosed Type 2 Diabetes

Diabetologia

English

Identification of the Secreted Proteins Originated From Primary Human Hepatocytes and HepG2 Cells

English

Related publications

Baseline Characteristics in the VERIFY Study: A Randomized Trial Assessing the Durability of Glycaemic Control With Early Vildagliptin-Metformin Combination in Newly Diagnosed Type 2 Diabetes

English

Pronounced Reduction of Cutaneous Langerhans Cell Density in Recently Diagnosed Type 2 Diabetes

English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology

2015

English

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences

2016

English

Paradoxical Glycaemic Response to Surgical Treatment of Ovarian Hyperthecosis in a Patient With Type 2 Diabetes

British Journal of Diabetes and Vascular Disease

Internal Medicine

Cardiology

Endocrinology

Cardiovascular Medicine

Metabolism

Diabetes

2015

English

Evolutionary Structural and Functional Conservation of an Ortholog of the GLUT2 Glucose Transporter Gene (SLC2A2) in Zebrafish

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Physiology

2009

English

Early Glycaemic Control in Metformin Users Receiving Their First Add-On Therapy: A Population-Based Study of 4,734 People With Type 2 Diabetes

English

Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally

English

Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jörg Kotzka

A Variant of the Glucose Transporter Gene SLC2A2 Modifies the Glycaemic Response to Metformin Therapy in Recently Diagnosed Type 2 Diabetes

Identification of the Secreted Proteins Originated From Primary Human Hepatocytes and HepG2 Cells

Related publications

Baseline Characteristics in the VERIFY Study: A Randomized Trial Assessing the Durability of Glycaemic Control With Early Vildagliptin-Metformin Combination in Newly Diagnosed Type 2 Diabetes

Pronounced Reduction of Cutaneous Langerhans Cell Density in Recently Diagnosed Type 2 Diabetes

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

Paradoxical Glycaemic Response to Surgical Treatment of Ovarian Hyperthecosis in a Patient With Type 2 Diabetes

Evolutionary Structural and Functional Conservation of an Ortholog of the GLUT2 Glucose Transporter Gene (SLC2A2) in Zebrafish

Early Glycaemic Control in Metformin Users Receiving Their First Add-On Therapy: A Population-Based Study of 4,734 People With Type 2 Diabetes

Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally

Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes